Vimarsana
Biggest News Aggregation in the World

Page 9 - Buzz Show News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Buzz Show. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Buzz Show Today - Breaking & Trending Today

"The Buzz" Show: Magna International Inc. (NYSE: MGA) Announces Joint Venture with LG - Vimarsana News

"The Buzz" Show: Magna International Inc. (NYSE: MGA) Announces Joint Venture with LG

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Magna International Inc. Announces Joint Venture with LG” Magna International Inc. (NYSE: MGA) shot up over 11% in premarket trading after the company announced its joint venture with LG. The companies will now seek to manufacture e-motors, inverters and on board chargers and, for certain automakers, related e-drive systems to support the growing global shift toward vehicle electrification.  Magna is a mobility technology company with more than 157,000 entrepreneurial-minded employees and 344 manufacturin...

"The Buzz" Show: Ocugen Inc. (NASDAQ: OCGN) Announces Binding Letter of Intent with Bharat Biotech - Vimarsana News

"The Buzz" Show: Ocugen Inc. (NASDAQ: OCGN) Announces Binding Letter of Intent with Bharat Biotech

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Ocugen Inc. Surges After Announcing Binding Letter of Intent with Bharat Biotech” Ocugen Inc. (NASDAQ: OCGN) shot up over 63% in premarket trading after announcing a binding letter of intent with Bharat Biotech to develop the latter’s COVAXIN vaccine candidate for the United States market. COVAXIN™ has been evaluated in approximately 1,000 subjects in Phase 1 and Phase 2 clinical trials in India and is currently part of a Phase 3 clinical trial involving 26,000 volunteers. Ocugen, Inc. is a biopharmace...

"Behind the Buzz" Show: Meten EdtechX Group Ltd. (NASDAQ: METX) Corporate Overview - Vimarsana News

"Behind the Buzz" Show: Meten EdtechX Group Ltd. (NASDAQ: METX) Corporate Overview

Sponsored Content Release FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content ...

"Behind the Buzz" Show: Plurilock Security Inc. (OTC: PLCKF) (TSX-V: PLUR) Corporate Overview - Vimarsana News

"Behind the Buzz" Show: Plurilock Security Inc. (OTC: PLCKF) (TSX-V: PLUR) Corporate Overview

Sponsored Content Release FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our...

"The Buzz" Show: Sonoma Pharmaceuticals (NASDAQ: SNOA) Enters Partnership with Crown Laboratories - Vimarsana News

"The Buzz" Show: Sonoma Pharmaceuticals (NASDAQ: SNOA) Enters Partnership with Crown Laboratories

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Sonoma Pharmaceuticals Enters Partnership with Crown Laboratories” Sonoma Pharmaceuticals (NASDAQ: SNOA) soared over 112% in premarket trading on after it entered into a license and supply agreement to launch Microcyn® Technology-Based Anti-Itch Over-the-Counter Products. The agreement gives Crown Laboratories the exclusive rights to sell and market Sonoma’s Microcyn® technology dermal sprays and gels targeting itch and pain within the United States. Sonoma Pharmaceuticals is a global healthcare leader...